Tuberculosis and its fight throughout the ages
DOI:
https://doi.org/10.5281/zenodo.15312605Keywords:
Infectious Disease, Tuberculosis, Directly Observed Treatment, WHOAbstract
In the World Health Organization (WHO) Global Tuberculosis Report-2024, it was announced that tuberculosis (TB), the deadliest infectious disease for centuries, has caused one billion deaths in the last 200 years, returned to its former place in the first place in the ranking of causes of death due to single-source infectious disease in 2023 after the COVID-19 pandemic, and that multidrug-resistant TB is still an important public health problem. Wars, migrations, HIV and COVID-19 pandemics, inequalities, inadequate political determination and resource allocations, inadequate research and development activities and problems in managing all these situations have been important factors in the incidence and fatalities of TB. In this review; the course and struggle of TB disease throughout human history is presented chronologically. Scientists and their studies, approaches of country administrations, WHO strategies and practices, United Nations meetings and resolutions that have made significant contributions to the understanding and fight against the disease are summarized. In the fight against tuberculosis, the financing problem in underdeveloped countries where the disease is common, the attitude of the senior leaders of the countries, new screening methods and vaccines, drugs developed in the fight against multidrug resistance are explained.
References
Natarajan A, Beena PM, Devnikar AV, Mali S. A systemic review on tuberculosis. Indian J Tuberc. 2020 Jul;67(3):295-311. doi: 10.1016/j.ijtb.2020.02.005. Epub 2020 Feb 28. PMID: 32825856.
Paulson, T. Epidemiology: A mortal foe. Nature 502, S2-3 (2013)
Global tuberculosis report 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO.
Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global tuberculosis report 2020-reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis 2021; 113: 7-12.
Global tuberculosis report 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
Stone AC, Wilbur AK, Buikstra JE, Roberts CA. Tuberculosis and leprosy in perspective. Am J Phys Anthropol. 2009; 140 Suppl 49:66 94
Kappelman J, Alçiçek MC, Kazanci N, Schultz M, Ozkul M, Sen S. First Homo erectus from Turkey and implications for migrations into temperate Eurasia. Am J Phys Anthropol. 2008; 135 (1):110 6
Brosch, R. Gordon SV, Marmiesse M, Brodin P,Buchrieser C, Eiglmeier K, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. 99, 3684–3689 (2002).
Comas, I, Coscolla M, Luo T, Borrell S, Holt KE, Kato-Maeda M, et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat. Genet. 45, 1176–82 (2013).
Brites, D. & Gagneux, S. Co-evolution of Mycobacterium tuberculosis and Homo sapiens. Immunol. Rev. 2015; 264, 6–24.
Chisholm RH, Trauer JM, Curnoe D, Tanaka MM. Controlled fire use in early humans might have triggered the evolutionary emergence of tuberculosis. Proc. Natl. Acad. Sci. USA 113, 9051–6 (2016)
Morse D, Brothwell DR, Ucko PJ. Tuberculosis in ancient Egypt. Am Rev Respir Dis. 1964;90:524-41.
Barberis I, Bragazzi NL, Galluzzo L, Martini M. The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus. J Prev Med Hyg. 2017 Mar;58(1):E9-E12. PMID: 28515626; PMCID: PMC5432783.
Agarwal Y, Chopra RK, Gupta DK, Sethi RS. The tuberculosis timeline: Of white plague, a birthday present, and vignettes of myriad hues. Astrocyte 2017;4:7-26
Zysk, Kenneth G. Medicine in the Veda: Religious Healing in the Veda. New Delhi: Motilal Banarsidas. 1998.
Hippocrates (460-370 BCE). Book 1 - Of the epidemics. In: Adams F (Ed.). The genuine works of Hippocrates. London: The Sydenham Society 1849.
Adams F, editör. Hipokrat'ın hakiki eserleri. Londra: Sydenham Derneği; 1849. Kitap 1 – Salgınlar hakkında. Hipokrat (MÖ 460-370).
Roberts CA, Buikstra JE. The bioarchaeology of tuberculosis. A global view on a reemerging disease. Gainesville, FL: University of Florida Press; 2003
Frith J. History of tuberculosis Part 1 – Pthisis, consumption and the White Plague. Journal of Military and Veterans’ Health 2014;22(2).
Gurunluoglu R, Gurunluoglu A. Paul of Aegina: landmark in surgical progress. World J Surg 2003;27(1):18-25
Herzog H. History of tuberculosis. Respiration 1998; 65: 5‑15
Saeed BW. Malignant tuberculosis. J Ayub Med Coll Abbottabad 2006;18(3):1-2.
Sabbatani S. Historical insights into tuberculosis. Girolamo Fracastoro’s intuition on the transmission of tuberculosis and his opponents. History of an idea. Infez Med 2004;12(4):284-91
O’Connor TM. Tuberculosis: overview. In: Reference Module in Biomedical Sciences, from International Encyclopedia of Public Health. New York, NY: Elsevier 2008, pp. 408-14.
Daniel TM, The history of tuberculosis. Respiratory Medicine (2006) 100, 1862–1870
Daniel TM. Captain of death: the story of tuberculosis. Rochester, NY: University of Rochester Press 1997.
Daniel TM. Pioneers in Medicine and their Impact on Tuberculosis. Rochester, NY: University of Rochester Press 2000, pp. 4, 29, 46-48, 50-51, 74-76.
Dormandy T. The White Death: a history of tuberculosis. London: The Hambledon press 1999, pp. 2, 4, 13
Roguin A. Rene Theophile Hyacinthe Laennec (1781‑1826): The man behind the stethoscope. Clin Med Res 2006; 4 (3): 230‑235
Typy M.L, Bailey R. Trouncing Tuberculosis Erişim linki; https://humanprogress.org/trends/trouncing-tuberculosis/ Erişim tarihi:05.01.2025
Blevins S M, Bronze MS. Robert Koch and the ‘golden age’ of bacteriology. International Journal of Infectious Diseases 14 (2010) e744–e751
Koch R. The etiology of tuberculosis (1884). In: Carter KC; translator. Essays of Robert Koch. Connecticut: Greenwood Press; 1987. p. 129–50.
Daniel TM. Robert Koch and the pathogenesis of tuberculosis. Int J Tuberc Lung Dis 2005;9:1181–2.
Sakula A. Robert Koch: centenary of the discovery of the tubercle bacillus, 1882. Thorax 1982;37:246–51.
Gradmann C. Robert Koch and the pressures of scientific research: tuberculosis and tuberculin. Medical History 2001;45(1):1-32
Luca S, Mihaescu T. History of BCG Vaccine. Maedica (Bucur). 2013 Mar;8(1):53-8. PMID: 24023600; PMCID: PMC3749764.
Tekin AC. 1939-1950 Yılları Arasında Türkiye’de Veremle Mücadele Faaliyetleri. Journal of Universal History Studies (JUHIS) 2018; I(1):1–21
Final Report of the First Executive Board of the United Nations International Children’s Emergency Fund. 11 December 1946 - 31 December 1950. Erişim adresi: https://www.unicef.org/media/85601/file/first-exec-board-final-report-1950.pdf Erişim tarihi:23.02.2025
Comstock GW. The International Tuberculosis Campaign: a pioneering venture in mass vaccination and research. Clin Infect Dis. 1994 Sep;19(3):528-40. doi: 10.1093/clinids/19.3.528. PMID: 7811874.
Murray JF, Schraufnagel DE, Hopewell PC. Treatment of Tuberculosis. A Historical Perspective. Ann Am Thorac Soc. 2015 Dec;12(12):1749-59. doi: 10.1513/AnnalsATS.201509-632PS. PMID: 26653188.
Hinshaw HC, Feldman WH, Pfuetze KH. Treatment of tuberculosis with streptomycin; a summary of observations on one hundred cases. J Am Med Assoc 1946;132:778–782.
Swedish National Association against Tuberculosis, Therapeutic Trials Committee. para-Aminosalicylic acid treatment in pulmonary tuberculosis. Am Rev Tuberc 1950;61:597–612.
British Thoracic and Tuberculosis Association. Short-course chemotherapy in pulmonary tuberculosis: a controlled trial by the British Thoracic and Tuberculosis Association. Lancet 1976;2:1102–1104
Singh H, Rupal A, Al Omari O, Jani C, Ahmed A, Khaliqdina S, Walker A, Shalhoub J, Thomson C, Marshall DC, Salciccioli JD. Trends in pulmonary tuberculosis mortality between 1985 and 2018: an observational analysis. BMC Pulm Med. 2023 May 26;23(1):184. doi: 10.1186/s12890-023-02458-9. PMID: 37237250; PMCID: PMC10224609.
Gallant, Victor, Venkata Duvvuri, and Manson McGuire. "Tuberculosis in Canada-summary 2015." Canada Communicable Disease Report 43.3-4 (2017): 77.
United Nations Press Release, H/2903, 22 March 199; World Health Organızatıon Says Tuberculosıs Deaths Reach Hıstorıc Levels. Erişim adresi: https://press.un.org/en/1996/19960322.h2903.html. Erişim tarihi: 23.02.2025
MC Raviglione, A Pio, Evolution of WHO policies for tuberculosis control, 1948–2001,The Lancet, 2002;volüme 359, Issue 9308;775-780, ISSN 0140-6736,
Dolin PJ, Raviglione MC, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72(2):213-20. PMID: 8205640; PMCID: PMC2486541.
Bloch, AB, Cauthen, GM, Onorato, IM, ve diğerleri. Amerika Birleşik Devletleri'nde ilaca dirençli tüberkülozun ülke çapındaki araştırması. JAMA 1994;271:665-671
Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb). 2003;83(1-3):4-14. doi: 10.1016/s1472-9792(02)00071-9. PMID: 12758183.
What is DOTS? Erişim adresi: https://iris.who.int/bitstream/handle/10665/65979/WHO_CDS_CPC_TB_99.270.pdf Erişim tarihi:25.02.2025
Murali MS, Sajjan BS. DOTS strategy for control of tuberculosis epidemic. Indian J Med Sci. 2002 Jan;56(1):16-8. PMID: 12508626.
World Health Organization. Global Tuberculosis Programme. Global Tuberculosis Control. WHO Report 1998. Geneva, Switzerland, WHO/TB/98-237
The Global Plan to Stop Tb 2006-2015: Progress Report 2006-2008. Actıons For Lıfe: Buıldıng A Succesful Future Together. Pages 8-9
Mario C. Raviglione, The TB epidemic from 1992 to 2002. Tuberculosis, Volume 83, Issues 1–3, 2003, Pages 4-14
Resolution WHA58.14. Sustainable financing for tuberculosis prevention and control. In: Fifty-eighth World Health Assembly. Geneva, 16–25 May 2005. Resolutions and decisions. Geneva, World Health Organization, 2005 (WHA58/2005/REC/1), Annex: 79–81.
Türk Tabipleri Birliği Tüberküloz Raporu. Birinci Bölüm;Tüberküloz Gerçeği. Birinci Baskı, Ocak 2012, Ankara. Türk Tabipleri Birliği Yayınları. s:7
World Health Organization. Tuberculosis. The End TB Strategy. https://www.who.int/teams/global-tuberculosis-programme/the-end-tb-strategy
Global tuberculosis report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC
Pai M. Time for high-burden countries to lead the tuberculosis research agenda. PLoS Med. 2018 Mar 23;15(3):e1002544. doi:10.1371/journal.pmed.1002544. PMID: 29570726; PMCID: PMC5865711.
Moscow Declaration to End TB; First WHO global ministerial conference on ending TB in the sustainable development era: a multisectoral response. Geneva: World Health Organization and the Ministry of Health of the Russian Federation; 2017 (https://iris.who.int/handle/10665/345527).
Goletti D, Al-Abri S, Migliori GB, Arlehamn CL, Haldar P, Sundling C, da Costa C, To KW, Martineau AR, Petersen E, Zumla A, Shan Lee S. World Tuberculosis Day 2024 theme "Yes! We can end TB" can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease. Int J Infect Dis. 2024 Apr;141S:106993. doi: 10.1016/j.ijid.2024.106993. Epub 2024 Mar 7. PMID: 38458422.
TB infection tests that are currently recommended by WHO. Erişim adresi:https://tbksp.who.int/en/node/2398 Erişim tarihi:10.03.2025
Global tuberculosis report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.
Updated WHO consolidated guidelines on DR-TB treatment 2025. Erişim adresi: https://vmc.euro.who.int/vmc/public/Files/Public/Webinars/1%20Updated%20WHO%20recommendations%20and%20guidance%20on%20treatment%20of%20DR-TB_EURO%20VMC%20ENG.pdf. Erişim tarihi:18.03.2025
World Health Organization. World Tuberculosis Day 2024. Erişim adresi: https://www.who.int/campaigns/world-tb-day/2024. Erişim tarihi:19.03.2025
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 HALK SAĞLIĞI ARAŞTIRMA VE UYGULAMALARI DERGİSİ
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
